Perspective Therapeutics, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-KT
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
144
3
4
4/A
424B3
424B5
8-A12B
8-A12G
8-K
8-K/A
AW
CERTAMX
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
EFFECT
FWP
NT 10-K
NT 10-Q
NTN 10K
POS AM
POS EX
POSASR
PRE 14A
PREM14A
REGDEX
REGDEX/A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0000728387-26-000004 | Mar 16, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0000728387-26-000003 | Mar 16, 2026 | — |
| SCHEDULE 13G | — | 0000919574-26-001548 | Mar 10, 2026 | — |
| 4 | 4 | 0001761768-26-000003 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001748615-26-000002 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001397331-26-000002 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001283301-26-000008 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001393007-26-000002 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001535289-26-000003 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001375410-26-000003 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001965071-26-000002 | Mar 4, 2026 | Mar 2, 2026 |
| SCHEDULE 13G | — | 0000895421-26-000048 | Feb 12, 2026 | — |
| SCHEDULE 13G | — | 0001831942-26-000003 | Feb 9, 2026 | — |
| SCHEDULE 13G | — | 0001193125-26-041315 | Feb 6, 2026 | — |
| SCHEDULE 13G | — | 0001441449-26-000003 | Feb 5, 2026 | — |
| 8-K | 8-K | 0001193125-26-035508 | Feb 3, 2026 | Feb 2, 2026 |
| 424B5 | 424B5 | 0001193125-26-034003 | Feb 3, 2026 | — |
| FWP | FWP | 0001193125-26-032708 | Feb 2, 2026 | — |
| 8-K | 8-K | 0001193125-26-032706 | Feb 2, 2026 | — |
| 8-K | 8-K | 0001193125-26-012259 | Jan 14, 2026 | — |
| 8-K | 8-K | 0001193125-26-009846 | Jan 12, 2026 | — |
| 8-K | 8-K | 0001193125-26-008277 | Jan 9, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002958 | Dec 5, 2025 | — |
| 8-K | 8-K | 0001193125-25-303895 | Dec 1, 2025 | — |
| 4 | 4 | 0001193125-25-283953 | Nov 17, 2025 | Nov 13, 2025 |
| 4 | 4 | 0001193125-25-281626 | Nov 14, 2025 | Nov 12, 2025 |
| 10-Q | 10-Q | 0001193125-25-274328 | Nov 10, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-274318 | Nov 10, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002922 | Nov 7, 2025 | — |
| 8-K | 8-K | 0001193125-25-268124 | Nov 6, 2025 | — |
| 8-K | 8-K | 0001193125-25-262636 | Nov 3, 2025 | — |
| 8-K | 8-K | 0001193125-25-242912 | Oct 20, 2025 | — |
| 8-K | 8-K | 0001193125-25-225858 | Oct 1, 2025 | — |
| 4 | 4 | 0000950170-25-113245 | Sep 5, 2025 | Sep 4, 2025 |
| 3 | 3 | 0000950170-25-113244 | Sep 5, 2025 | Sep 4, 2025 |
| 4 | 4 | 0000950170-25-113243 | Sep 5, 2025 | Sep 3, 2025 |
| 3 | 3 | 0000950170-25-113242 | Sep 5, 2025 | Sep 3, 2025 |
| 8-K | 8-K | 0000728387-25-000013 | Sep 4, 2025 | Sep 2, 2025 |
| 8-K | 8-K | 0000728387-25-000010 | Sep 3, 2025 | Sep 2, 2025 |
| 8-K | 8-K | 0000728387-25-000006 | Sep 2, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-107619 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-107609 | Aug 13, 2025 | — |
| 8-K | 8-K | 0000950170-25-101414 | Aug 1, 2025 | — |
| 8-K | 8-K | 0000950170-25-093556 | Jul 3, 2025 | — |
| 8-K | 8-K | 0000950170-25-088700 | Jun 23, 2025 | Jun 21, 2025 |
| 8-K | 8-K | 0000950170-25-080568 | Jun 3, 2025 | — |
| 8-K | 8-K | 0000950170-25-079876 | May 30, 2025 | — |
| 8-K | 8-K | 0000950170-25-078439 | May 28, 2025 | — |
| SD | SD | 0000950170-25-074522 | May 19, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-069314 | May 12, 2025 | Mar 31, 2025 |